ArticleBiomedicines2024

Co-Administration of Proton Pump Inhibitors May Negatively Affect the Outcome in Inflammatory Bowel Disease Treated with Vedolizumab.

Kata Szemes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.